PHASE I DOSE ESCALATION STUDY OF PEMETREXED AND CARBOPLATIN IN CHEMOTHEARPY-NAIVE ELDERLY PATIENTS WITH ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER.

被引：0

作者：

Takeoka, Hiroaki ^{[1
]}

Yamada, Kazuhiko ^{[1
]}

Zaizen, Yoshiaki ^{[1
]}

Shimamatsu, Fumie ^{[1
]}

Azuma, Koichi ^{[1
]}

Hoshino, Tomoaki ^{[1
]}

机构：

[1] Kurume Univ, Sch Med, Kurume, Fukuoka, Japan

来源：

JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷

关键词：

non-small cell lung cancer; elderly; Carboplatin; pemetrexed;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P2.10-002

引用

页码：S859 / S859

页数：1

共 50 条

[41] A phase II study of biweekly paclitaxel and carboplatin in elderly patients with advanced non-small cell lung cancer
Kenzo Soejima
Katsuhiko Naoki
Kota Ishioka
Morio Nakamura
Michie Nakatani
Ichiro Kawada
Hideo Watanabe
Ichiro Nakachi
Hiroyuki Yasuda
Ryosuke Satomi
Sohei Nakayama
Satoshi Yoda
Sinnosuke Ikemura
Hideki Terai
Takashi Sato
Keiko Ohgino
Daisuke Arai
Tetsuo Tani
Aoi Kuroda
Makoto Nishino
Tomoko Betsuyaku
Cancer Chemotherapy and Pharmacology, 2015, 75 : 513 - 519
[42] A Randomized Phase 3 Trial Comparing Pemetrexed/Carboplatin and Docetaxel/Carboplatin as First-Line Treatment for Advanced, Nonsquamous Non-small Cell Lung Cancer
Rodrigues-Pereira, Jose
Kim, Joo-Hang
Magallanes, Manuel
Lee, Dae Ho
Wang, Jie
Ganju, Vinod
Martinez-Barrera, Luis
Barraclough, Helen
van Kooten, Maximiliano
Orlando, Mauro
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (11) : 1907 - 1914
[43] Pemetrexed plus carboplatin or oxaliplatin in advanced non-small cell lung cancer
Scagliotti, GV
SEMINARS IN ONCOLOGY, 2005, 32 (02) : S5 - S8
[44] Phase I dose escalation study of pemetrexed and concurrent thoracic radiation in elderly patients with non-squamous non-small-cell lung cancer
Kaira, Kyoichi
Ono, Akihiro
Kamide, Yosuke
Sunaga, Noriaki
Koga, Yasuhiko
Saitoh, Jun-ichi
Shirai, Katsuyuki
Ebara, Takeshi
Hisada, Takeshi
Ishizuka, Tamotsu
JOURNAL OF RADIATION RESEARCH, 2019, 60 (02) : 228 - 233
[45] Gemcitabine and low dose carboplatin in the treatment of elderly patients with advanced non-small cell lung cancer
Maestu, I
Gómez-Aldaraví, L
Torregrosa, MD
Camps, C
Llorca, C
Bosch, C
Gómez, J
Giner, V
Oltra, A
Albert, A
LUNG CANCER, 2003, 42 (03) : 345 - 354
[46] A phase II trial of first-line bevacizumab in combination with pemetrexed and carboplatin in advanced nonsquamous non-small cell lung cancer (NSCLC)
Skaff, Z. G.
Hageboutros, A.
Krieger, K.
Coakley, S.
Somer, R.
Stevenson, J.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
[47] Outcome of elderly patients with advanced non-small cell lung cancer.
Gumus, M
Palak, B
Iyikesici, S
Yumuk, PF
Seker, M
Topal, A
Dane, F
Salepci, T
Yayla, A
Turhal, NS
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 706S - 706S
[48] Phase I dose escalation study of immunoconjugate L-DOS47 in combination with pemetrexed/carboplatin in non-squamous non-small cell lung cancer (NSCLC) patients.
Dowlati, Afshin
Belani, Chandra Prakash
Simon, George R.
Chao, Heman
Piha-Paul, Sarina Anne
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[49] PHASE I STUDY OF TISLELIZUMAB IN COMBINATION WITH BEVACIZUMAB AND PEMETREXED IN FIRST-LINE TREATMENT FOR ADVANCED ELDERLY NONSQUAMOUS NON-SMALL CELL LUNG CANCER: TRIAL IN PROGRESS
Ren, Xiubao
Liu, Liang
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A737 - A737
[50] Pharmacogenetic study of Japanese patients with advanced nonsquamous non-small cell lung cancer treated with pemetrexed plus cisplatin
Imai, Hisao
Serizawa, Masakuni
Takahashi, Toshiaki
Mori, Keita
Ono, Akira
Akamatsu, Hiroaki
Taira, Tetsuhiko
Nakamura, Yukiko
Kenmotsu, Hirotsugu
Naito, Tateaki
Murakami, Haruyasu
Koh, Yasuhiro
Endo, Masahiro
Nakajima, Takashi
Yamamoto, Nobuyuki
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)

← 1 2 3 4 5 →